We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Edwards Lifesciences Corp | NYSE:EW | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.37 | -0.44% | 84.30 | 85.725 | 83.50 | 84.25 | 2,203,110 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form SD
SPECIALIZED DISCLOSURE REPORT
EDWARDS LIFESCIENCES CORPORATION
(Exact Name of Registrant as Specified in Charter)
Delaware | 1-15525 | 36-4316614 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File No.) |
(I.R.S. Employer Identification Number) |
One Edwards Way, Irvine, California | 92614 | |
(Address of Principal Executive Offices) | (Zip Code) |
Aimee S. Weisner (949) 250-2500
(Name and telephone number, including area code,
of the person to contact in connection with this report.)
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
☒ Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2018.
Item 1.01 Conflict Minerals Disclosure Report
A copy of the conflict minerals report is publicly available on Edwards website at www.edwards.com under About Us Corporate Responsibility Sustainability Responsible Supply Chain, or directly at http://ir.edwards.com/responsible-supply-chain.
Item 1.02 Exhibit
A copy of the conflict minerals report is attached hereto as Exhibit 1.01 and incorporated herein by this reference.
Section 2 Exhibits
Item 2.01 Exhibits
Exhibit No. |
Description |
|
1.01 | Conflict Minerals Report as contemplated by Item 1.02 of this Form. |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
EDWARDS LIFESCIENCES CORPORATION | ||||||
May 31, 2019 | By: | /s/ Aimee S. Weisner | ||||
Aimee S. Weisner | ||||||
Corporate Vice President, | ||||||
General Counsel |
2
1 Year Edwards Lifesciences Chart |
1 Month Edwards Lifesciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions